FOX CHASE CANCER CENTER
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1904-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.foxchase.org
Next Generation Sequence Target-Directed Therapy in Treating Patients With Cancer
- Conditions
- Interventions
- First Posted Date
- 2014-05-07
- Last Posted Date
- 2021-02-04
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT02132845
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Facilitating Participation in a Prostate Cancer Risk Assessment Program
- Conditions
- Interventions
- First Posted Date
- 2014-04-30
- Last Posted Date
- 2017-04-06
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 128
- Registration Number
- NCT02126319
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver
- Conditions
- Interventions
- First Posted Date
- 2014-04-10
- Last Posted Date
- 2018-02-26
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 2
- Registration Number
- NCT02110953
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine Tumors
- Conditions
- Interventions
- First Posted Date
- 2014-03-20
- Last Posted Date
- 2019-07-23
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 90
- Registration Number
- NCT02092714
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer
- Conditions
- Interventions
- First Posted Date
- 2014-03-17
- Last Posted Date
- 2024-01-16
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 44
- Registration Number
- NCT02088775
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Conditions
- Interventions
- First Posted Date
- 2014-01-30
- Last Posted Date
- 2019-02-20
- Lead Sponsor
- Fox Chase Cancer Center
- Registration Number
- NCT02050009
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
- First Posted Date
- 2013-11-13
- Last Posted Date
- 2017-06-15
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 115
- Registration Number
- NCT01982591
- Locations
- 🇺🇸
Paoli Memorial Hospital, Paoli, Pennsylvania, United States
🇺🇸Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- First Posted Date
- 2013-10-16
- Last Posted Date
- 2024-03-26
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT01962948
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Trial of Print Messages to Support the Role of Partners in Promoting Provider Discussions About Prostate Cancer Screening Among AA Men
- Conditions
- Interventions
- First Posted Date
- 2013-09-09
- Last Posted Date
- 2013-09-09
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 231
- Registration Number
- NCT01937585
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2013-09-04
- Last Posted Date
- 2018-02-07
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 6
- Registration Number
- NCT01934179
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States